Clinical trial

Gallium-68 PSMA-11 PET in Participants With Prostate Cancer

NCT05034562

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2022-09-26

PhasePHASE2

Study timeline

Study start (actual)2022-09-26Date precision: day

Registry last updated2024-03-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Prostate Carcinomaunresolved

Recurrent Prostate Carcinomaunresolved

Stage IV Prostate Cancer AJCC v8unresolved

Stage IVA Prostate Cancer AJCC v8unresolved

Stage IVB Prostate Cancer AJCC v8unresolved

Interventions

Computed TomographyPROCEDURE

Gallium Ga 68-labeled PSMA-11DRUG

Magnetic Resonance ImagingPROCEDURE

Positron Emission TomographyPROCEDURE

Sponsors & collaborators

M.D. Anderson Cancer Centerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05034562 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.